Company Filing History:
Years Active: 2024
Title: Yao-Cheng Yang: Innovator in Lentivirus Technology
Introduction
Yao-Cheng Yang is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of lentivirus packaging systems. His innovative work has the potential to enhance gene delivery methods, which are crucial for various medical applications.
Latest Patents
Yao-Cheng Yang holds a patent for a lentivirus packaging system, which includes a transfer plasmid with a nucleotide sequence of TAR-reserved-chimeric 5' long terminal repeat (LTR). The system also comprises at least one packaging plasmid that encodes TAR RNA binding protein, rev gene, gag gene, and pol gene, along with an envelope plasmid. This invention allows for the production of lentivirus with higher virus titer, improving the transduction rate and gene delivery efficiency during cell transduction. Furthermore, the patent outlines methods for enhancing lentivirus production in host cells and utilizing transduced cells for cancer treatment.
Career Highlights
Yao-Cheng Yang is associated with Pell Bio-med Technology Co., Ltd., where he continues to advance his research and development efforts. His work is instrumental in pushing the boundaries of gene therapy and cancer treatment methodologies.
Collaborations
Yao-Cheng has collaborated with notable colleagues such as Wei-Chi Lin and Ssu-Yu Chou, contributing to the collective expertise in their field.
Conclusion
Yao-Cheng Yang's innovative contributions to lentivirus technology exemplify the potential of biotechnology in medical advancements. His work not only enhances the efficiency of gene delivery but also opens new avenues for cancer treatment.